Product Images Terazosin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Terazosin Hydrochloride NDC 68788-9817 by Preferred Pharmaceuticals, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

59746 383 06

59746 383 06

59746 384 06

59746 384 06

This is a description of Terazosin Hydrochloride capsules, a medication used for treating high blood pressure and benign prostatic hyperplasia (BPH). The package contains 2mg capsules of Terazosin Hydrochloride equivalent, generic for Hytrin. The medication is produced by Jubilant Cadista Pharmaceuticals Inc. with each capsule containing terazosin-Hydrochloride. The text also has instructions regarding the warning that prohibits the transfer of medication prescribed to others. The text contains the batch number, the expiry date, and the National Drug Code (NDC) number.*

59746 385 06

59746 385 06

Terazosin Hydrochloride Capsules are a medication used for treating symptoms of an enlarged prostate. Each capsule contains 5mg of Terazosin Hydrochloride and is a generic version of the medication Hytrin. The medication should only be taken by the patient it was prescribed for as the transfer of medication to others is prohibited under federal law. The medication is manufactured by Jubilant Cadista Pharmaceuticals and comes in a package size of 5. The expiration date and lot number are also provided.*

Terazosin Hydrochloride Chemical Structure - terazosin hydrochloride capsules 1

Terazosin Hydrochloride Chemical Structure - terazosin hydrochloride capsules 1

Figure 1 - terazosin hydrochloride capsules 2

Figure 1 - terazosin hydrochloride capsules 2

Figure 2 - terazosin hydrochloride capsules 3

Figure 2 - terazosin hydrochloride capsules 3

The text appears to be a table indicating the mean change from baseline over a period of time, with measurements taken at month 0, 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30. However, without additional context or information, it is difficult to determine what the baseline and changes are referring to.*

Figure 3 - terazosin hydrochloride capsules 4

Figure 3 - terazosin hydrochloride capsules 4

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.